Puesta al día

Obstrucción del intestino delgado por adherencias

Una puesta al día sobre los mecanismos y su prevención.

Autor/a: Dres. Attard J-A P, MacLean AR.

Fuente: Can J Surg 2007; 50(4): 291-300

Indice
1. Bibliografía
2. Desarrollo

1. Vrijland WW, Jeekel J, van Geldorp HJ, et al. Abdominal adhesions: intestinal obstruction, pain, and infertility. Surg Endosc 2003;17:1017-22.
2. Sulaiman H, Dawson L, Laurent GJ, et al. Role of plasminogen activators in peritoneal adhesion formation. Biochem Soc Trans 2002;30:126-31.
3. Vrijland WW, Tseng LN, Eijkman HJ, et al. Fewer intraperitoneal adhesions with use of hyaluronic acid-carboxymethylcellulose membrane: a randomized clinical trial. Ann Surg 2002;235:193-9.
4. Dijkstra FR, Nieuwenhuijzen M, Reijnen MM, et al. Recent clinical developments in pathophysiology, epidemiology, diagnosis and treatment of intra-abdominal adhesions. Scand J Gastroenterol Suppl 2000;232:52-9.
5. Menzies D, Ellis H. Intestinal obstruction from adhesions–how big is the problem? Ann R Coll Surg Engl 1990;72:60-3.
6. Monk BJ, Berman ML, Montz FJ. Adhesions after extensive gynecologic surgery: clinical significance, etiology, and prevention. Am J Obstet Gynecol 1994;170: 1396-403.
7. Johnston S, O’Malley K, McEntee G, et al. The need to retrieve the dropped stone during laparoscopic cholecystectomy. Am J Surg 1994;167:608-10.
8. Ellis H, Moran BJ, Thompson JN, et al. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet 1999;353: 1476-80.
9. Zbar RI, Crede WB, McKhann CF, et al. The postoperative incidence of small bowel obstruction following standard, open appendectomy and cholecystectomy: a six-year retrospective cohort study at Yale-New Haven Hospital. Conn Med 1993;57:123-7.
10. Ahlberg G, Bergdahl S, Rutqvist J, et al. Mechanical small-bowel obstruction after conventional appendectomy in children. Eur J Pediatr Surg 1997;7:13-5.
11. Beck DE, Opelka FG, Bailey HR, et al. Incidence of small-bowel obstruction and adhesiolysis after open colorectal and general surgery. Dis Colon Rectum 1999;42: 241-8.
12. Nieuwenhuijzen M, Reijnen MM, Kuijpers JH, et al. Small bowel obstruction after total or subtotal colectomy: a 10-year retrospective review. Br J Surg 1998; 85:1242-5.
13. MacLean AR, Cohen Z, MacRae HM, et al. Risk of small bowel obstruction after the ileal pouch-anal anastomosis. Ann Surg 2002;235:200-6.
14. Fazio VW, Ziv Y, Church JM, et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 1995;222:120-7.
15. Marcello PW, Roberts PL, Schoetz DJ Jr, et al. Obstruction after ileal pouch-anal anastomosis: a preventable complication? Dis Colon Rectum 1993;36:1105-11.
16. Francois Y, Dozois RR, Kelly KA, et al. Small intestinal obstruction complicating ileal pouch-anal anastomosis. Ann Surg 1989;209:46-50.
17. Bryant T. Clinical lectures on intestinal obstruction. Med Times Gaz 1872;1:363-5.
18. Stovall TG, Elder RF, Ling FW. Predictors of pelvic adhesions. J Reprod Med 1989;34:345-8.
19. Sulaiman H, Gabella G, Davis MC, et al. Presence and distribution of sensory nerve fibers in human peritoneal adhesions. Ann Surg 2001;234:256-61.
20. Van Der Krabben AA, Dijkstra FR, Nieuwenhuijzen M, et al. Morbidity and mortality of inadvertent enterotomy during adhesiotomy. Br J Surg 2000;87:467-71.
21. Cheong YC, Laird SM, Li TC, et al. Peritoneal healing and adhesion formation/ reformation. Hum Reprod Update 2001; 7:556-66.
22. Ray NF, Denton WG, Thamer M, et al. Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg 1998;186:1-9.
23. Ivarsson ML, Holmdahl L, Franzen G, et al. Cost of bowel obstruction resulting from adhesions. Eur J Surg 1997;163:679-84.
24. Holmdahl L. Making and covering of surgical footprints. Lancet 1999;353:1456-7.
25. Holmdahl L, Ivarsson ML. The role of cytokines, coagulation, and fibrinolysis in peritoneal tissue epair. Eur J Surg 1999; 165:1012-9.
26. Buckman RF, Woods M, Sargent L, et al. A unifying pathogenetic mechanism in the etiology of intraperitoneal adhesions. J Surg Res 1976;20:1-5.
27. Reijnen MM, Bleichrodt RP, Van Goor H. Pathophysiology of intra-abdominal adhesion and abscess formation, and the effect of hyaluronan. Br J Surg 2003; 90:533-41.
28. Reed KL, Fruin AB, Bishop-Bartolomei KK, et al. Neurokinin-1 receptor and substance P messenger RNA levels increase during intraabdominal adhesion formation. J Surg Res 002;108:165-72.
29. Rout UK, Diamond MP. Role of plasminogen activators during healing after uterine serosal lesioning in the rat. Fertil Steril 2003;79:138-45.
30. Herrick SE, Mutsaers SE, Ozua P, et al. Human peritoneal adhesions are highly cellular, innervated, and vascularized. J Pathol 2000;192:67-72.
31. Holmdahl L, Eriksson E, al Jabreen M, et al. Fibrinolysis in human peritoneum during operation. Surgery 1996;119:701-5.
32. Ivarsson ML, Bergstrom M, Eriksson E, et al. Tissue markers as predictors of postoperative adhesions. Br J Surg 1998;85: 1549-54.
33. Moore KL, Bang NU, Broadie TA, et al. Peritoneal fibrinolysis: evidence for the efficiency of the tissue-type plasminogen activator. J Lab Clin Med 1983;101:921-9.
34. Raftery AT. Effect of peritoneal trauma on peritoneal fibrinolytic activity and intraperitoneal adhesion formation. An experimental study in the rat. Eur Surg Res 1981;13:397-401.
35. Vipond MN, Whawell SA, Thompson JN, et al. Peritoneal fibrinolytic activity and intra-abdominal adhesions. Lancet 1990; 335:1120-2.
36. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;331:1286-92.
37. Tietze L, Elbrecht A, Schauerte C, et al. Modulation of pro- and antifibrinolytic properties of human peritoneal mesothelial cells by transforming growth factor beta1 (TGF-beta1), tumor necrosis factor alpha (TNF-alpha) and interleukin 1beta (IL1beta). Thromb Haemost 1998;79:362-70.
38. Williams RS, Rossi AM, Chegini N, et al. Effect of transforming growth factor beta on postoperative adhesion formation and intact peritoneum. J Surg Res 1992;52: 65-70.
39. Lucas PA, Warejcka DJ, Young HE, et al. Formation of abdominal adhesions is inhibited by antibodies to transforming growth factor-beta1. J Surg Res 1996; 65:135-8.
40. Holmdahl L, Kotseos K, Bergstrom M, et al. Overproduction of transforming growth factor-beta1 (TGF-beta1) is associated with adhesion formation and peritoneal fibrinolytic impairment. Surgery 2001;129:626-32.
41. Tsukada K, Katoh H, Shiojima M, et al. Concentrations of cytokines in peritoneal fluid after abdominal surgery. Eur J Surg 1993;159:475-9.
42. Whawell SA, Thompson JN. Cytokineinduced release of plasminogen activator inhibitor-1 by human mesothelial cells. Eur J Surg 1995;161:315-8.
43. Kaidi AA, Gurchumelidze T, Nazzal M, et al. Tumor necrosis factor-alpha: a marker for peritoneal adhesion formation. J Surg Res 1995;58:516-8.
44. Sturiale S, Barbara G, Qiu B, et al. Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc Natl Acad Sci U S A 1999;96:11653-8.
45. Reed KL, Fruin AB, Gower AC, et al. A neurokinin 1 receptor antagonist decreases postoperative peritoneal adhesion formation and increases peritoneal fibrinolytic activity. Proc Natl Acad Sci U S A 2004; 101:9115-20.
46. Gutt CN, Oniu T, Schemmer P, et al. Fewer adhesions induced by laparoscopic surgery? Surg Endosc 2004;18:898-906.
47. Reduction of postoperative pelvic adhesions with intraperitoneal 32% dextran 70: a prospective, andomized clinical trial. Fertil Steril 1983;40:612-9.
48. Goldberg EP, Sheets JW, Habal MB. Peritoneal adhesions: prevention with the use of hydrophilic polymer coatings. Arch Surg 1980;115:776-80.
49. Fukasawa M, Girgis W, diZerega GS. Inhibition of postsurgical adhesions in a standardized rabbit model: II. Intraperitoneal treatment with heparin. Int J Fertil 1991;36:296-301.
50. Jackson EK. Intraperitoneal administration of adenosine inhibits formation of abdominal adhesions. Dis Colon Rectum 2004;47:1390-6.
51. Replogle RL, Johnson R, Gross RE. Prevention of postoperative intestinal adhesions with combined promethazine and dexamethasone therapy: experimental and clinical studies. Ann Surg 1966;163:580-8.
52. Montz FJ, Monk BJ, Lacy SM, et al. Ketorolac tromethamine, a nonsteroidal antiinflammatory drug: ability to inhibit post-radical pelvic surgery adhesions in a porcine model. Gynecol Oncol 1993;48:76-9.
53. Siegler AM, Kontopoulos V, Wang CF. Prevention of postoperative adhesions in rabbits with ibuprofen, a nonsteroidal antiinflammatory agent. Fertil Steril 1980; 34:46-9.
54. Steinleitner A, Lambert H, Kazensky C, et al. Pentoxifylline, a methylxanthine derivative, prevents postsurgical adhesion reformation in rabbits. Obstet Gynecol 1990;75: 926-8.
55. Steinleitner A, Kazensky C, Lambert H. Calcium channel blockade prevents postsurgical reformation of adnexal adhesions in rabbits. Obstet Gynecol 1989;74:796-8.
56. de la PF. Ynfante I, Bejarano D, et al. Prevention of peritoneal adhesions by intraperitoneal administration of vitamin E: an experimental study in rats. Dis Colon Rectum 2004;47:2157-61.
57. Hellebrekers BW, Trimbos-Kemper TC, Trimbos JB, et al. Use of fibrinolytic agents in the prevention of postoperative adhesion formation. Fertil Steril 2000;74: 203-12.
58. Montz FJ, Fowler JM, Wolff AJ, et al. The ability of recombinant tissue plasminogen activator to inhibit post-radical pelvic surgery adhesions in the dog model. Am J Obstet Gynecol 1991;165:1539-42.
59. Nagler A, Genina O, Lavelin I, et al. Halofuginone, an inhibitor of collagen type I synthesis, prevents postoperative adhesion formation in the rat uterine horn model. Am J Obstet Gynecol 1999;180: 558-63.
60. Young RL, Cota J, Zund G, et al. The use of an amniotic membrane graft to prevent postoperative adhesions. Fertil Steril 1991;55:624-8.
61. Yemini M, Shoham Z, Katz Z, et al. Effectiveness of silicone sheeting in preventing the formation of pelvic adhesions. Int J Fertil 1989;34:71-3.
62. Prevention of postsurgical adhesions by Interceed (TC7), an absorbable adhesion barrier: a prospective randomized multicenter clinical study. Interceed (TC7) Adhesion Barrier Study Group. Fertil Steril 1989;51:933-8.
63. Bellon JM, Bujan J, Contreras LA, et al. Use of nonporous polytetrafluoroethylene prosthesis in combination with polypropylene prosthetic abdominal wall implants in prevention of peritoneal adhesions. J Biomed Mater Res 1997;38:197-202.
64. Becker JM, Dayton MT, Fazio VW, et al. Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg 1996;183:297-306.
65. Zong X, Li S, Chen E, et al. Prevention of postsurgery-induced abdominal adhesions by electrospun bioabsorbable nanofibrous poly(lactide-co-glycolide)-based membranes. Ann Surg 2004;240:910-5.
66. Avital S, Bollinger TJ, Wilkinson JD, et al. Preventing intra-abdominal adhesions with polylactic acid film: an animal study. Dis Colon Rectum 2005;48:153-7.
67. Holtz G. Failure of a nonsteroidal anti-inflammatory agent (ibuprofen) to inhibit peritoneal adhesion reformation after lysis. Fertil Steril 1982;37:582-3.
68. Risberg B. Adhesions: preventive strategies. Eur J Surg Suppl 1997;577:32-9.
69. Grosfeld JL, Berman IR, Schiller M, et al. Excessive morbidity resulting from the prevention of intestinal adhesions with steroids and antihistamines. J Pediatr Surg 1973;8:221-6.
70. James DC, Ellis H, Hugh TB. The effect of streptokinase on experimental intraperitoneal adhesion formation. J Pathol Bacteriol 1965;90:279-87.
71. Nagler A, Rivkind AI, Raphael J, et al. Halofuginone–an inhibitor of collagen type I synthesis–prevents postoperative formation of abdominal adhesions. Ann Surg 1998;227:575-82.
72. Hellebrekers BW, Trimbos-Kemper GC, van Blitterswijk CA, et al. Effects of five different barrier materials on postsurgical adhesion formation in the rat. Hum Re-prod 2000;15:1358-63.
73. Montz FJ, Monk BJ, Lacy SM. The Gore-Tex surgical membrane: effectiveness as a barrier to inhibit postradical pelvic surgery adhesions in a porcine model. Gynecol Oncol 1992;45:290-3.
74. Reijnen MM, Falk P, Van Goor H, et al. The antiadhesive agent sodium hyaluronate increases the proliferation rate of human peritoneal mesothelial cells. Fertil Steril 2000;74:146-51.
75. Diamond MP. Reduction of de novo postsurgical adhesions by intraoperative precoating with Sepracoat (HAL-C) solution: a prospective, randomized, blinded, placebo-controlled multicenter study. The Sepracoat Adhesion Study Group. Fertil Steril 1998;69:1067-74.
76. Beck DE, Cohen Z, Fleshman JW, et al. A prospective, randomized, multicenter, controlled study of the safety of Seprafilm adhesion barrier in abdominopelvic surgery of the intestine. Dis Colon Rectum 2003;46:1310-9.